✦ LIBER ✦

TP53 mutations in familial breast cancer: Functional aspects

✍ Scribed by Milena Gasco; Isik G Yulug; Tim Crook

Publisher: John Wiley and Sons
Year: 2003
Tongue: English
Weight: 112 KB
Volume: 21
Category: Article
ISSN: 1059-7794
DOI: 10.1002/humu.10173

No coin nor oath required. For personal study only.

✦ Synopsis

Mutation in p53 (TP53) remains one of the most commonly described genetic events in human neoplasia. The occurrence of mutations is somewhat less common in sporadic breast carcinomas than in other cancers, with an overall frequency of about 20%. There is, however, evidence that p53 is mutated at a significantly higher frequency in breast carcinomas arising in carriers of germ-line BRCA1 and BRCA2 mutations. Some of the p53 mutants identified in BRCA1 and BRCA2 mutation carriers are either previously undescribed or infrequently reported in sporadic human cancers. Functional characterization of such mutants in various systems has revealed that they frequently possess properties not commonly associated with those occurring in sporadic cases: they retain apoptosis-inducing, transactivating, and growth-inhibitory activities similar to the wild-type protein, yet are compromised for transformation suppression and also possess an independent transforming phenotype. The occurrence of such mutants in familial breast cancer implies the operation of distinct selective pressures during tumorigenesis in BRCA-associated breast cancers.

📜 SIMILAR VOLUMES

TP53 mutation in colorectal cancer

✍ Barry Iacopetta 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 125 KB

Approximately half of all colorectal cancers show p53 (TP53) gene mutations, with higher frequencies observed in distal colon and rectal tumors and lower frequencies in proximal tumors and those with the microsatellite instability or methylator phenotypes. Alterations to this gene appear to have lit

No germline TP53 mutations detected in f

No germline TP53 mutations detected in familial and bilateral testicular cancer

✍ Ketil Heimdal; Ragnhild A. Lothe; Sigrid Lystad; Ruth Holm; Sophie D. Fosså; Pro 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 448 KB

Mutations in the TP53 gene are considered to be among the most common genetic alterations in human cancers. Both somatic and germline mutations have been found. Using polymerase chain reaction (PCR). constant denaturant gel electrophoresis (CDGE), and denaturing gradient gel electrophoresis (DGGE),

TP53 mutations in human skin cancers

✍ Giuseppina Giglia-Mari; Alain Sarasin 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 444 KB

The p53 gene (TP53) is mutated in numerous human cancers. We have used it as a molecular target to characterize the induction of mutations in human skin cancers. About 50% of all skin cancers in normal individuals exhibit p53 mutations. This frequency rises to 90% in skin cancers of patients with th

TP53 gene mutations in plasma DNA of can

TP53 gene mutations in plasma DNA of cancer patients

✍ Jose M. Silva; Rocio Gonzalez; Gemma Dominguez; Jose M. Garcia; Pilar España; Fe 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 70 KB 👁 2 views

Using different molecular techniques, DNA has been shown to be present in plasma of patients with several types of tumors. Mutations of TP53 are the most common genetic changes in human cancers. We investigated the presence of TP53 gene mutations in plasma DNA of breast and small cell lung cancer pa

Specificity of TP53 mutation screening m

Specificity of TP53 mutation screening methods in cancerous tissues

✍ Jean Breton; Mathilde Lechevrel; François Sichel 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 French ⚖ 87 KB

BRCA1 germline mutations in Indian famil

BRCA1 germline mutations in Indian familial breast cancer

✍ Mani T. Valarmathi; Agarwal A.; Suryanarayana S. V. Deo; Nootan K. Shukla; Satya 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 57 KB 👁 2 views

Germline mutation analysis of BRCA1 gene has demonstrated significant allelic heterogeneity. These differences represent historical influences of migration, population structure and geographic or cultural isolation. To date, there have been no reports of Indian families with mutations in BRCA1. We h